The dynamic changes a lot because the drug does not exist. It costs $750M to research and develop so nobody bothers unless it's a common enough disease that it can be paid for with what people feel is a "moral price." It seems people only care about marginal cost of production in their moral calculus.
Let's say the drug costs $750M to develop, $1/dose to produce, sales are free and no other fixed costs exist. Let's also pretend that you can sell during the full patent period of 20 years, but expect to be out-competed by generics after that. Also you need one dose per day.
750 million divided by 20 years and 365 days per year is 106000 (rounded up).
The company could sell the medication for
1) $107 per dose, 1000 people can afford it and the company makes $0 profit.
2) $1000 per dose, 900 people can afford it, the company makes $880 profit per dose, for a total of $792,000/day
3) $10000 per dose, 100 people can afford it, the company makes $9882 profit per dose, for a total of $988,200
The research raises the lowest viable cost, and becomes more expensive per dose as you make fewer doses, but with an example as extreme as GPs it doesn't really matter (with the exception that we now have to assume the existence of some kind of insurance with copay, otherwise I don't know how 900 people afford $365k/year in medical costs). And you can still come in with the offer to purchase 1000 doses per day at a price that satisfies both sides.
You just hit upon the problem.
> Some families spend thousands of dollars each year to buy orphan drugs, which are drugs that have received a special designation from the U.S. Food and Drug Administration. About 1 in 8 families [with children taking orphan drugs] paid more than $2,000 a year in 2018 – double the percentage who spent that much in 2013.[0]
Put that up against the US median household income of $67.5k (or $46.6k for black households)[1], and you've got yourself a significant expense. Keep in mind, this is only the median income. 8.7% of households make between $15-25k per year[1] and probably can't afford the copays, much less the insurance.
If it's a scenario where it's "take the drug or a kid dies," more than 1/10th of those kids die, absent any outside financial help. And, that would be quite a lot of financial help, too.
Let's not also forget this kid is probably uninsurable, so, they'll have to have group health insurance for the entirre rest of their lives. Better not get fired from your job when you're past 26, kiddo!
---
[0]: https://labblog.uofmhealth.org/lab-notes/big-costs-for-small...
[1]: https://www.census.gov/library/publications/2021/demo/p60-27...
The reasonable way to run health insurance is what most European countries do, with various implementations: you get health insurance when you are born, and you can't get out. That way the insurance can actually work as an insurance (averaging out risk), can't be gamed, everyone is covered, and if your work isn't your insurance you have a freer labor market.
Can we observe this anomalies(giants, monopolies,duopolies, cartels , ) appearing then try different strategies to prevent that to happen? Would be cool to maybe do a search algorithm to find the best strategy to distribute money, healthcare, education to as many people as possible and could be also cool to test your own ideas, like maybe I am thinking that a tax/regulation for X would have some good effect, I could put it in the simulation and maybe discover something I did not anticipated.
In that context it's important to note that collective bargaining is very much a feature of a pure capitalistic system. Just as the supply side seeks advantages by forming monopolies or cartels, the demand side seeks advantages by forming unions or purchasing pools. Both sides face similar challenges with this, like holding the group together and prevent betrayal (so you have to set up a Nash equilibrium where any one party leaving loses from doing so). You can certainly end up with universal healthcare in a pure capitalistic system because for the buyer side it decreases risk (because of the insurance characteristics) and lowers costs (due to the collective bargaining).
But of course most Western countries resolve this kind of conundrum in healthcare with collective bargaining, whether that's at the government level or at the insurance level (which only really works if you ensure absolutely everyone has insurance). If the offer is "we will buy 1000 doses/year for no more than $15 each" the dynamic changes a lot.